Darlene Dobkowski, MA | Authors


Promising ICIS Are Explored in Sarcoma, But Disparate Histologies Are Challenging

March 22, 2022

Patients with sarcoma may respond to treatment with immune checkpoint inhibitors, but identifying patients who are most likely to respond to this therapy is an ongoing obstacle and suggests the need for further research.